- Home
- AUDC vs GALT Comparison
AUDC vs GALT Comparison
Compare AUDC & GALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AUDC | GALT |
|---|---|---|
| Founded | 1992 | 2000 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 245.9M | 199.2M |
| IPO Year | 2000 | 2008 |
Fundamental Metrics
Financial Performance| Metric | AUDC | GALT |
|---|---|---|
| Price | $9.07 | $2.83 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $12.50 | $8.50 |
| AVG Volume (30 Days) | 121.9K | ★ 297.5K |
| Earning Date | 05-05-2026 | 05-15-2026 |
| Dividend Yield | ★ 4.54% | N/A |
| EPS Growth | N/A | ★ 36.84 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.24 | N/A |
| Revenue Next Year | $2.18 | N/A |
| P/E Ratio | $23.06 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.95 | $1.85 |
| 52 Week High | $11.48 | $7.13 |
Technical Indicators
Market Signals| Indicator | AUDC | GALT |
|---|---|---|
| Relative Strength Index (RSI) | 45.34 | 64.21 |
| Support Level | $8.71 | $2.62 |
| Resistance Level | $9.82 | $3.36 |
| Average True Range (ATR) | 0.37 | 0.18 |
| MACD | -0.10 | 0.04 |
| Stochastic Oscillator | 11.48 | 85.19 |
Price Performance
Historical ComparisonAbout AUDC AudioCodes Ltd.
AudioCodes Ltd provides voice communications solutions for enterprises, contact centers, and service providers, including voice infrastructure, cloud-based platforms, and Voice AI applications. Its AudioCodes Live Platform is a cloud-based service delivery platform that enables provisioning, management, and operation of voice and AI-based communication services, including PSTN connectivity and integration with platforms such as Microsoft Teams, Webex Calling, and Zoom Phone. The company's solutions are organized into three layers: voice infrastructure and devices, cloud-based platforms, and Voice AI applications for contact center and productivity use cases. It also offers management tools such as One Voice Operations Center (OVOC), Device Manager, and AudioCodes Routing Manager (ARM).
About GALT Galectin Therapeutics Inc.
Galectin Therapeutics Inc is a clinical-stage biopharmaceutical company. The company focuses on drug research and development to create new therapies for fibrotic disease, cancer, and selected other diseases. Its galectin-3 inhibitor is belapectin (GR-MD-02), which has been demonstrated in preclinical models to reverse liver fibrosis and cirrhosis.